ArticleCancer biomarkers : section A of Disease markers2016

MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer.

Julien Adam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.